loading

Finanzdaten der Greenwich Lifesciences Inc-Aktie (GLSI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
10.54%
2.5372
2.836 2.5029 1.7478 2.2411
Operating Income/Loss
10.54%
-2.5372
-2.836 -2.5029 -1.7478 -2.2411
Income/Loss From Continuing Operations Before Tax
9.96%
-2.4732
-2.7467 -2.3918 -1.6284 -2.1249
Income/Loss From Continuing Operations After Tax
9.96%
-2.4732
-2.7467 -2.3918 -1.6284 -2.1249
Net Income/Loss
9.96%
-2.4732
-2.7467 -2.3918 -1.6284 -2.1249
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
12.86
- - - -
Diluted Average Shares
12.86
- 12.85 12.85 -
Basic Earnings Per Share
9.52%
-0.19
-0.21 -0.19 -0.13 -0.17
Diluted Earnings Per Share
9.52%
-0.19
-0.21 -0.19 -0.13 -0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$146.84
price down icon 2.64%
$85.00
price down icon 0.01%
$25.75
price down icon 0.17%
$84.20
price down icon 2.90%
$447.85
price down icon 0.91%
$249.03
price up icon 3.56%
Kapitalisierung:     |  Volumen (24h):